(Q45192678)

10 December 2017

Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin (English)

1 reference

10 December 2017

1 reference

J Chiang

1

1 reference

10 December 2017

C A Gloff

series ordinal

2

1 reference

10 December 2017

C N Yoshizawa

series ordinal

3

1 reference

10 December 2017

G J Williams

series ordinal

4

1 reference

10 December 2017

1 April 1993

1 reference

10 December 2017

Pharmaceutical Research

1 reference

10 December 2017

10

1 reference

10 December 2017

567-572

1 reference

10 December 2017

4

1 reference

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

10 December 2017

1 reference

12 December 2020

Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial

1 reference

12 December 2020

Interferon-gamma for the treatment of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responses.

1 reference

12 December 2020

Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha

1 reference

12 December 2020

Interferons: from virus inhibitor to modulator of amino acid and lipid metabolism

1 reference

12 December 2020

Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.

1 reference

12 December 2020

Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine

1 reference

12 December 2020

In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS)

1 reference

12 December 2020

Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse

1 reference

12 December 2020

Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.

1 reference

12 December 2020

The role of IFN-beta in cancer therapy.

1 reference

12 December 2020

Selective induction of mononuclear phagocytes to produce neopterin by interferons

1 reference

12 December 2020

Site-specific mutagenesis of the human fibroblast interferon gene

1 reference

12 December 2020

Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018902120023

1 reference

10 December 2017

1 reference